fluoxetine has been researched along with Cerebromeningitis in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enterovirus infections pose a serious threat for patients with humoral deficiencies and may be lethal, whilst the efficacy of proposed treatment options such as corticosteroids, intravenous immunoglobulins and fluoxetine remains debated." | 4.12 | Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis. ( Boeckx, N; Demaerel, P; Dubois, B; Jentjens, S; Kuppeveld, FJM; Laenen, L; Lens, G; Thal, DR; van der Elst, KCM; Van Nieuwenhuyse, T; Verhaert, N; Vermeersch, G; Woei-A-Jin, FJSH; Wollants, E, 2022) |
| " The present study aimed to validate the efficacy of selective serotonin reuptake inhibitors, fluoxetine hydrochloride (FLH) and paroxetine hydrochloride (PAH), alone and in combination with amphotericin B (AmB) against C." | 1.62 | In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans. ( de Menezes, RT; de Oliveira, HC; de Oliveira, LD; Pereira, TC; Scorzoni, L, 2021) |
| "cruzi-induced depression is independent of active or prior CNS inflammation." | 1.38 | Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions. ( de Almeida, LR; de Souza, AS; Lannes-Vieira, J; Moreira, OC; Pereira, IR; Rocha, MS; Silva, AA; Silva, RR; Vilar-Pereira, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Vermeersch, G | 1 |
| Laenen, L | 1 |
| Lens, G | 1 |
| van der Elst, KCM | 1 |
| Thal, DR | 1 |
| Jentjens, S | 1 |
| Demaerel, P | 1 |
| Van Nieuwenhuyse, T | 1 |
| Wollants, E | 1 |
| Boeckx, N | 1 |
| Verhaert, N | 1 |
| Dubois, B | 1 |
| Kuppeveld, FJM | 1 |
| Woei-A-Jin, FJSH | 1 |
| Pereira, TC | 1 |
| de Menezes, RT | 1 |
| de Oliveira, HC | 1 |
| de Oliveira, LD | 1 |
| Scorzoni, L | 1 |
| Vilar-Pereira, G | 1 |
| Silva, AA | 1 |
| Pereira, IR | 1 |
| Silva, RR | 1 |
| Moreira, OC | 1 |
| de Almeida, LR | 1 |
| de Souza, AS | 1 |
| Rocha, MS | 1 |
| Lannes-Vieira, J | 1 |
3 other studies available for fluoxetine and Cerebromeningitis
| Article | Year |
|---|---|
Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis.
Topics: Antiviral Agents; Echovirus Infections; Enterovirus B, Human; Enterovirus Infections; Fluoxetine; Hu | 2022 |
In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Cryptococcosis; Cryptococcus neoformans; Drug Synergism | 2021 |
Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions.
Topics: Animals; Antidepressive Agents, Second-Generation; Chagas Disease; Depression; Emotions; Exploratory | 2012 |